CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 19 enrolled
Drug / intervention
Micropulse Laser Treatment +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03519581
NCT03519581N/ACompleted
CompareCT.gov

Micropulse for Suppression of Diabetic Macular Edema

University of California, Davis·interventional·Posted May 9, 2018·Updated Dec 17, 2024

In Brief

A clinical study evaluating Micropulse Laser Treatment and Sham Treatment for Diabetic Macular Edema. Completed, enrolled 19 participants across 1 site.

Detailed Summary

Diabetic retinopathy is one of the most common complications of diabetes and diabetic macular edema (DME) is one of the most common causes of vision loss in diabetes. The purpose of this study is to determine if early intervention with micropulse laser treatment in eyes with good visual acuity (20/32 or better) will improve or stabilize vision loss due to the complications of diabetic macular edema.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetic Macular Edema
CountriesUnited States
CollaboratorsIRIDEX Corporation

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedMay 9, 2018
Enrollment StartApr 20, 2018
Primary CompletionJan 31, 2023
TodayJul 2, 2026
Enrollment to primary: 4.8 yearsPosted 8.1 years ago

Interventions

Micropulse Laser Treatmentdevice

Participant's study eye will be dilated prior to being comfortably seated at the slit lamp for treatment. Application of micropulse laser on retinal surface will occur using TxCell Scanning Delivery System in a 7 x 7 grid to surround the fovea.

Sham Treatmentdevice

Participant's study eye will be dilated prior to being comfortably seated at the slit lamp for treatment. No actual laser treatment will occur.